Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 50.20
+4.55 (9.97%)
Nov 13, 2026, 1:21 PM CST
Oneness Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 926.74 | 1,659 | 1,048 | 812.83 | 5,655 | 332.96 |
Short-Term Investments | 4,436 | 4,165 | 5,971 | 6,960 | 2,392 | 7,473 |
Cash & Short-Term Investments | 5,362 | 5,823 | 7,019 | 7,773 | 8,047 | 7,806 |
Cash Growth | -8.92% | -17.03% | -9.70% | -3.40% | 3.08% | -6.14% |
Accounts Receivable | 15.32 | 46.81 | 18.34 | 25.77 | 13.08 | 14.59 |
Other Receivables | 130.8 | 95.83 | 77.88 | 50.77 | 19.86 | 114.2 |
Receivables | 146.12 | 142.64 | 96.22 | 76.54 | 32.95 | 128.79 |
Inventory | 107.91 | 108.89 | 115.16 | 122.74 | 111.4 | 81.32 |
Other Current Assets | 36.96 | 83.16 | 62.83 | 45.93 | 42.2 | 35.31 |
Total Current Assets | 5,653 | 6,158 | 7,293 | 8,018 | 8,233 | 8,051 |
Property, Plant & Equipment | 907.74 | 994.89 | 1,106 | 1,195 | 1,033 | 1,038 |
Long-Term Investments | 3,068 | 3,146 | 3,737 | 4,096 | 3,920 | 3,871 |
Goodwill | - | 57.44 | 57.44 | 89.14 | 89.14 | 89.14 |
Other Intangible Assets | 843.19 | 933.83 | 1,125 | 1,682 | 2,010 | 2,388 |
Long-Term Accounts Receivable | - | 11.42 | - | - | - | 32.41 |
Long-Term Deferred Tax Assets | 237.25 | 238.82 | 137.57 | 79.21 | 97.46 | 62.85 |
Other Long-Term Assets | 200.41 | 192.92 | 204.05 | 204.05 | 197.65 | 197.86 |
Total Assets | 10,910 | 11,734 | 13,660 | 15,364 | 15,580 | 15,731 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.32 | 3.6 | 2.73 | 1.7 | 1.52 | 2.5 |
Accrued Expenses | - | 415.18 | 103.57 | 119.05 | 155.39 | 78.16 |
Current Portion of Leases | 43.91 | 42.96 | 41.18 | 34.25 | 13.25 | 12.73 |
Current Income Taxes Payable | 0.42 | 0.87 | 0.12 | 0.12 | 12.69 | 35.1 |
Other Current Liabilities | 107.64 | 58.8 | 35.32 | 60.24 | 25.76 | 28.75 |
Total Current Liabilities | 154.29 | 521.42 | 182.92 | 215.36 | 208.6 | 157.24 |
Long-Term Leases | 294.4 | 327.77 | 365.18 | 397.95 | 250.09 | 270.34 |
Long-Term Unearned Revenue | 170.08 | 169.52 | 170.68 | 176.07 | 145.99 | 1,155 |
Long-Term Deferred Tax Liabilities | 239.79 | 237.26 | 140.41 | 76.56 | 95.22 | 58.18 |
Other Long-Term Liabilities | 0.47 | 0.47 | 0.47 | 0.48 | 0.48 | 0.48 |
Total Liabilities | 859.04 | 1,256 | 859.65 | 866.43 | 700.38 | 1,642 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 4,805 | 4,802 | 4,791 | 4,545 | 3,910 | 3,853 |
Additional Paid-In Capital | 5,505 | 6,515 | 7,623 | 9,050 | 8,637 | 9,469 |
Retained Earnings | -118.46 | -1,038 | -1,154 | -1,267 | 359.98 | -1,036 |
Treasury Stock | -25.78 | -25.78 | -25.78 | -25.78 | -25.78 | -47.38 |
Comprehensive Income & Other | -259.02 | 78.11 | 1,066 | 1,750 | 1,737 | 1,778 |
Total Common Equity | 9,907 | 10,332 | 12,299 | 14,053 | 14,618 | 14,016 |
Minority Interest | 144 | 145.45 | 501.02 | 444.07 | 262.28 | 72.95 |
Shareholders' Equity | 10,051 | 10,477 | 12,800 | 14,497 | 14,880 | 14,089 |
Total Liabilities & Equity | 10,910 | 11,734 | 13,660 | 15,364 | 15,580 | 15,731 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 338.31 | 370.73 | 406.35 | 432.2 | 263.34 | 283.07 |
Net Cash (Debt) | 5,024 | 5,453 | 6,613 | 7,341 | 7,783 | 7,523 |
Net Cash Growth | -8.64% | -17.54% | -9.92% | -5.69% | 3.46% | -6.13% |
Net Cash Per Share | 10.50 | 11.37 | 13.83 | 15.50 | 16.50 | 16.52 |
Filing Date Shares Outstanding | 483.71 | 479.21 | 478.03 | 476.23 | 466.02 | 458.4 |
Total Common Shares Outstanding | 483.71 | 479.21 | 478.03 | 476.23 | 466.02 | 458.4 |
Working Capital | 5,499 | 5,637 | 7,110 | 7,803 | 8,025 | 7,894 |
Book Value Per Share | 20.48 | 21.56 | 25.73 | 29.51 | 31.37 | 30.58 |
Tangible Book Value | 9,064 | 9,340 | 11,117 | 12,282 | 12,519 | 11,539 |
Tangible Book Value Per Share | 18.74 | 19.49 | 23.26 | 25.79 | 26.86 | 25.17 |
Buildings | - | 640.6 | 640.27 | 637.35 | 602.54 | 580.99 |
Machinery | - | 555.57 | 554.04 | 547.55 | 522.99 | 456.01 |
Construction In Progress | - | 18.76 | 1.98 | 18.24 | - | 13.03 |
Leasehold Improvements | - | 61.91 | 58.15 | 27.56 | 14.56 | 14.01 |